The Clinical Data: Everything Published So Far Phase 1 First-in-Human (Oral Formulation) Published: The Lancet, June 2025 Participants: 144 adults with overweight or obesity (BMI 25.039.9), no diabetes Duration: Up to 12 weeks Dosing: Once-daily oral amycretin, up to 2 50 mg Results: - 50 mg dose: 10.4% mean body weight change - 2 50 mg dose: 13.1% mean body weight change - Placebo: 1.2% 13% weight loss in 12 weeks
This guide explains why facial tan lasts so long, how sun exposure affects your skins health, and what treatmentsboth natural and professionalcan help bring back your natural skin tone
BPC-157 has been shown to: Accelerate wound healing speeds up repair of muscles, tendons, ligaments, and bones
Zhang Y, Chen H, Li R, Sterling K, Song W